Blog

For the longest time, scientists haven’t had tools at their disposal to measure biological (as opposed to simple chronological) age. They finally found some doing research on worms and plan more studies as well. This is a big deal as

From Scientific American: “A new study shows that the cancer drugs imatinib (also known as Gleevec by Novartis) and sunitinib (Sutent, made by Pfizer) halt diabetes in mice. A team from the University of California, San Francisco and Berkeley-based drug

From the TimesOnline: “A woman has been given a new section of windpipe created from her own stem cells in an operation that could revolutionise surgery. Claudia Castillo, 30, who lives in Barcelona, has become the first person to be

Japanese consumers are known to be ardent gadget lovers, but that doesn’t mean that technology development is thriving in Japan. In fact, the country has been surprisingly inhospitable to entrepreneurs, as I recently discovered when I traveled to Tokyo for

From Bloomberg News: “Doctors may someday slow or reverse the aging process with drugs that stimulate the body to repair itself as a result of research undertaken by Pfizer Inc. Pfizer, the world’s largest drugmaker, will spend $100 million during

This is a great article by Joe Nocera of the New York Times on the effectiveness of bringing a business mindset to disease research. He interviews Michael J. Fox and Andy Grove on how the best ways to run a

According to Cnet News: “Philips Research is out with a new intelligent camera pill that can be electronically preprogrammed to deliver targeted doses of medicine to patients with digestive disorders such as Crohn’s disease, colitis, and colon cancer. The device

It’s been called the “rapture of the nerds,” but such derision didn’t stop an estimated 500 enthusiasts from showing up to the Singularity Institute’s conference in San Jose, Calif., last weekend to discuss the possibility of artificial intelligence overtaking that

From Financial Times: “A Sheffield company has launched a “virtual rat” computer programme, which it claims will mimic drug trials on animals. Simcyp, spun out of Sheffield University, has specialised for the past seven years in creating virtual populations, essentially

Chipmaker Intel said this week that despite its record US$10.2 billion in revenue for the third quarter, the company is worried that the global economic crisis will affect future performance. Despite such a general malaise across the industry, however, there